President Obama has promised to support a bold future for medicine where diagnostic testing and treatments aren’t just what’s best for most people – they’re what’s best for you. This “precision medicine” takes individual variations in our genes and environments into account. Getting there will require genetic and health data from as many people as possible to uncover relationships

Quick Read

IBM is looking to enhance the growth of its Watson Health business with the $2.6 billion purchase of Truven Health Analytics, which has data on the cost and treatment of more than 200 million patients.

Quick Read

The company that began as a source of genealogical data now hopes to marry that information with DNA data—and sell it for research

Quick Read

In a move that may have broad ramifications for the pharmaceutical industry, a small drug maker called Amarin AMRN -6.57% has filed a lawsuit against the FDA to argue that its right to distribute information about unapproved uses of a medicine is protected by the First Amendment

Quick Read